Retail & Wholesale » Retail | China National Accord Medicines Corp.

China National Accord Medicines Corp. B | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
26,690
30,088
46,527
48,050
47,442
50,933
Cost of Goods Sold (COGS) incl. D&A
24,584
27,755
41,425
42,997
42,638
45,250
Gross Income
2,106
2,333
5,102
5,053
4,804
5,683
SG&A Expense
1,056
1,162
3,386
3,369
3,310
3,985
EBIT
974
1,130
-
-
1,486
1,704
Unusual Expense
21
15
25
46
4
7
Non Operating Income/Expense
32
44
58
162
55
76
Interest Expense
244
209
222
195
201
280
Pretax Income
778
980
1,528
1,756
1,386
1,610
Income Tax
158
201
330
372
357
391
Equity in Affiliates
54
63
72
113
304
379
Consolidated Net Income
674
843
1,270
1,498
1,334
1,597
Net Income
657
821
1,144
1,386
1,220
1,434
Net Income After Extraordinaries
657
821
1,144
1,386
1,220
1,434
Net Income Available to Common
657
821
1,144
1,386
1,220
1,434
EPS (Basic)
2.28
2.39
2.70
3.27
2.85
3.35
Basic Shares Outstanding
288
344
423
424
428
428
EPS (Diluted)
2.28
2.39
2.70
3.27
2.85
3.35
Diluted Shares Outstanding
288
344
423
424
428
428
EBITDA
1,106
1,273
1,955
1,923
1,689
1,948
Other Operating Expense
76
40
32
18
8
6
Non-Operating Interest Income
6
11
23
35
40
96
Minority Interest Expense
17
22
126
111
114
163

About China National Accord Medicines

View Profile
Address
Accord Pharmaceutical Building
Shenzhen Guangdong 518029
China
Employees -
Website http://www.szaccord.com.cn
Updated 07/08/2019
China National Accord Medicines Corp. Ltd. engages in the research, development, and consultation services of pharmaceutical packaging materials and pharmaceutical industry products. It operates through the following segments: Group, Pharmaceutical Distribution, and Pharmaceutical Manufacturing. The Group segment engages in investing and managing the business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.